enVVeno Medical (NVNO) Interest Expenses (2017 - 2025)

enVVeno Medical's Interest Expenses history runs 9 years deep, the most recent figure standing at $26000.0 for Q4 2025.

• On a quarterly basis, Interest Expenses fell 91.5% year-over-year to $26000.0 in Q4 2025; TTM through Dec 2025 was $26000.0, a 91.5% decrease from a year earlier, with the FY2025 full-year figure at $399000.0, up 3.1% from the prior year.
• Interest Expenses slipped to $26000.0 in Q4 2025 per NVNO's latest filing, from $306000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $1.4 million in Q4 2023 and bottomed at $5000.0 in Q1 2022.
• The 5-year median for Interest Expenses is $87981.0 (2021), against an average of $266651.3.
• Across the five-year window, Interest Expenses sank 94.32% in 2022 and jumped 800.0% in 2023, its largest moves.
• Year by year, Interest Expenses stood at $340561.0 in 2021, then declined by 12.5% to $298000.0 in 2022, then soared by 384.56% to $1.4 million in 2023, then plunged by 78.81% to $306000.0 in 2024, then plunged by 91.5% to $26000.0 in 2025.
• Per Business Quant, the three latest NVNO Interest Expenses figures stand at $26000.0 (Q4 2025), $306000.0 (Q4 2024), and $1.4 million (Q4 2023).